Blue Owl Capital Holdings’s Verona Pharma VRNA Stock Holding History

Blue Owl Capital Holdings’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,347	Closed	-$98	–	87
2025 Q3	$98	Hold	18,347	–	–	﹤0.01%	72
2025 Q2	$1.74M	Hold	18,347	–	–	0.56%	32
2025 Q1	$1.16M	Buy	+18,347	New	+$1.1M	0.38%	32

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Blue Owl Capital Holdings's VRNA Position: Q4 2025 in Review

Blue Owl Capital Holdings sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 18,347 shares — an estimated $98 sold.

Blue Owl Capital Holdings first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $1.74M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Blue Owl Capital Holdings reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Blue Owl Capital Holdings sold 18,347 Verona Pharma shares in Q4 2025, an estimated $98.
Blue Owl Capital Holdings first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Blue Owl Capital Holdings's Verona Pharma position peaked at $1.74M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.